| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 25.739 | 82.791 | 53.422 | 19.571 | 61.290 | 9.588 | 382.919 | 206.673 |
| Total Income - EUR | - | - | 25.739 | 87.434 | 58.147 | 24.574 | 71.270 | 14.012 | 387.258 | 210.985 |
| Total Expenses - EUR | - | - | 20.037 | 40.590 | 50.004 | 16.453 | 44.743 | 16.985 | 172.464 | 100.883 |
| Gross Profit/Loss - EUR | - | - | 5.702 | 46.845 | 8.143 | 8.121 | 26.527 | -2.973 | 214.794 | 110.102 |
| Net Profit/Loss - EUR | - | - | 5.445 | 46.011 | 7.654 | 7.927 | 25.914 | -3.096 | 211.006 | 92.231 |
| Employees | - | - | 3 | 2 | 2 | 1 | 2 | 2 | 0 | 0 |
Check the financial reports for the company - Pauls Laboratory S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 50.115 | 43.889 | 38.382 | 32.491 | 28.962 | 24.081 | 44.069 | 38.303 |
| Current Assets | - | - | 6.031 | 51.835 | 14.693 | 26.199 | 33.141 | 5.505 | 237.247 | 79.204 |
| Inventories | - | - | 0 | 978 | 617 | 890 | 533 | 0 | 0 | 0 |
| Receivables | - | - | 1.005 | 6.406 | 3.201 | 1.485 | 2.137 | 1.652 | 215.313 | 68.585 |
| Cash | - | - | 5.026 | 44.451 | 10.875 | 23.824 | 30.471 | 3.853 | 21.934 | 10.619 |
| Shareholders Funds | - | - | 5.488 | 51.399 | 13.695 | 21.362 | 34.521 | 8.691 | 211.054 | 92.279 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 50.658 | 6.028 | 5.412 | 1.565 | 2.417 | 0 | 53.764 | 13.134 |
| Income in Advance | - | - | 0 | 38.297 | 33.969 | 35.762 | 25.165 | 20.895 | 16.497 | 12.094 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3250 - 3250" | |||||||||
| CAEN Financial Year |
3250
|
|||||||||
Comments - Pauls Laboratory S.r.l.